GESTIPHARMA
ActiveSummary
GESTIPHARMA has been active since 1983 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €815,663 and a net result of €77,529. Equity is shrinking by about 5.3% per year across the filed financial years. Its solvency ranks better than 92% of 10,789 sector peers (NACE 70, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
Overview
Activity
Business and other management consultancy
NACE 70200
1 site
Size
≈ €370,000turnover 2025, estimated
- Staff
- 1.3 FTE
- Equity
- €815,663
- Profit
- €77,529
Turnover estimated from the gross margin
Structure
- Holdings
- 1
- FINPHARMADirector · permanent representative BOULANGER Philippe
- Hecq PierreManaging director
2025 accounts 31 days early2 of 9 deeds summarised
Why 96lowers riskLiquidity: current ratio 9.41, cash €409,067Equity €815,663 (94.9% of total assets)Size: total assets €859,421Sector: Activities of head offices; management consultancy activities (NACE 70)Show the evidence
Checked score
Score 2025
96
/ 100
Excellent
Probability in this band: under 0.55%
Financially better than 72% of its sector peers (NACE 70, micro)
Financial strength · tick = 2024
Strong
Solvency
100=
equity 94.9% of total assets
Liquidity
100+10
short-term debt 5.1% · cash 47.6%
Profitability
80+18
return on assets 9.0%
Bankruptcy probability, 12 months
< 0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
11-2024: < 0.1%
12-2024: < 0.1%● unchanged vs 11-2024
01-2025: < 0.1%● unchanged vs 12-2024
02-2025: < 0.1%● unchanged vs 01-2025
03-2025: < 0.1%● unchanged vs 02-2025
04-2025: < 0.1%● unchanged vs 03-2025
05-2025: < 0.1%● unchanged vs 04-2025
06-2025: < 0.1%● unchanged vs 05-2025
07-2025: < 0.1%● unchanged vs 06-2025
08-2025: < 0.1%● unchanged vs 07-2025
09-2025: < 0.1%● unchanged vs 08-2025
10-2025: < 0.1%● unchanged vs 09-2025
11-2025: < 0.1%● unchanged vs 10-2025
12-2025: < 0.1%● unchanged vs 11-2025
01-2026: < 0.1%● unchanged vs 12-2025
02-2026: < 0.1%● unchanged vs 01-2026
03-2026: < 0.1%● unchanged vs 02-2026
04-2026: < 0.1%● unchanged vs 03-2026
05-2026: < 0.1%● unchanged vs 04-2026
06-2026: < 0.1%● unchanged vs 05-2026highest value
07-2026: < 0.1%● unchanged vs 06-2026lowest value
08-2026: < 0.1%● unchanged vs 07-2026lowest value
09-2026: < 0.1%● unchanged vs 08-2026lowest value
10-2026: < 0.1%● unchanged vs 09-2026lowest value
Credit of up to €75,000 on 30-day terms is acceptable
Liquidity ample (current ratio 9.41, compared with 8.31 in 2024, above the usual 1.5; short-term debt: 5.1% and cash: 47.6% of total assets), and 5.1% of the assets are financed with debt and provisions.
How it is calculated
The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 70, micro): better than 86% on solvency, 97% on liquidity, 47% on profitability and 58% on growth.
The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).
Credit check for your own amount and term
Show the recommended maximum and see how the verdict changes with amount, term and advance.
Signals
Five signals.
lowers riskneutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-06-2026, 31 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
31 days early
2024
17 days early
2023
6 days late
2022
23 days late
2021
16 days late
2020
9 days late
2019
25 days late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 4 days after the deadline; the sector median (NACE 70) for financial year 2024 is 9 days before the deadline, and 32% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 7 August (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven monthsWhere today falls in the filing period
31-10-2026 today31-12-2026 year end31-07-2027 deadline
- Annual accounts filedfinancial year 2025 · abbreviated…
- Back to profitnet €77,529
- Annual accounts filedfinancial year 2024 · micro…
Financials · financial year 2025, abbreviated format
Turnover
≈ €370,000
Estimated: probably between €300,000 and €480,000
EBIT margin
Not included in this filing
Net result
€77,529
2024 · -€40,570
Working capital
€367,878▲ 68.6%
2024 · €218,228
Trend over the years
2021 to 2025, 5 financial years 2018 to 2025, 8 financial years
The operating result returns to profit in 2025: €76,706 after a loss of €40,926 in 2024, the highest result in the available series.
What the company sold each financial year and what was left of it. A loss stands below the zero line.
Operating result€0.08m
2025
Net result€0.08m
2025
What the company owns (total assets), how much of it is its own (equity) and how much it owes.
Total assets€0.9m
2025
Equity€0.8m
2025
Debt€0.04m
2025
Short-term assets minus short-term debts. Above zero the company can pay its bills in the short term.
Working capital€0.4m
2025
How much of each euro of turnover is left from operations (EBIT margin) and what the assets earn (return on assets).
Return on assets (ROA)9.0%
2025
The share of the company financed with its own means. The higher it is, the better it absorbs a shock.
Solvency94.9%
2025
Short-term assets per euro of short-term debt. Above 1 the short-term debts are covered.
Current ratio9.41
2025
Average staff in full-time equivalents (FTE).
Staff (FTE)1.3
2025
Use the arrow keys on the chart for the figures per year.
Sector: the middle half of NACE 70, Activities of head offices; management consultancy activities: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA), Staff (FTE).
Every figure with its change against the financial year before
favourable
unfavourable
Line20182019202020212022202320242025
Operating result€0.09m--€0.03m-€0.06m▼ 140%-€0.04m▲ 29.2%-€0.09m▼ 110%€0.001m-€0.04m€0.08m
Net result€0.1m--€0.03m-€0.06mbelow the sector's middle half▼ 139%-€0.04mbelow the sector's middle half▲ 29.2%-€0.09mbelow the sector's middle half▼ 109%€0.001mbelow the sector's middle half-€0.04mbelow the sector's middle half€0.08mwithin the sector's middle half
Equity€1.0m-€1.0m▼ 2.6%€0.9mwithin the sector's middle half▼ 6.5%€0.9mabove the sector's middle half▼ 4.9%€0.8mabove the sector's middle half▼ 10.8%€0.8mabove the sector's middle half▲ 0.2%€0.7mabove the sector's middle half▼ 5.2%€0.8mwithin the sector's middle half▲ 10.5%
Total assets€1.0m-€1.0m▼ 6.2%€1.0mwithin the sector's middle half▼ 3.2%€0.9mabove the sector's middle half▼ 7.4%€0.8mabove the sector's middle half▼ 10.6%€0.8mabove the sector's middle half▲ 3.0%€0.8mabove the sector's middle half▼ 5.3%€0.9mwithin the sector's middle half▲ 11.9%
Debt€0.04m-€0.003m▼ 92.4%€0.03m▲ 998%€0.009m▼ 73.3%€0.01m▲ 2.7%€0.03m▲ 235%€0.03m▼ 6.7%€0.04m▲ 46.6%
Working capital-€0.03m-€0.03m€0.05mwithin the sector's middle half▲ 69.5%€0.1mwithin the sector's middle half▲ 87.9%€0.09mwithin the sector's middle half▼ 4.4%€0.2mabove the sector's middle half▲ 80.4%€0.2mabove the sector's middle half▲ 31.6%€0.4mabove the sector's middle half▲ 68.6%
Solvency96.0%-99.7%▲ 3.7pp96.3%above the sector's middle half▼ 3.3pp98.9%above the sector's middle half▲ 2.6pp98.8%above the sector's middle half▼ 0.2pp96.1%above the sector's middle half▼ 2.7pp96.1%above the sector's middle half▲ 0.1pp94.9%above the sector's middle half▼ 1.2pp
Current ratio0.20-10.52▲ 10.322.47within the sector's middle half▼ 8.0511.34above the sector's middle half▲ 8.8710.62above the sector's middle half▼ 0.726.18above the sector's middle half▼ 4.448.31above the sector's middle half▲ 2.139.41above the sector's middle half▲ 1.10
Return on assets (ROA)13.8%--2.7%▼ 16.5pp-6.7%below the sector's middle half▼ 4.0pp-5.1%below the sector's middle half▲ 1.6pp-11.9%below the sector's middle half▼ 6.8pp0.2%below the sector's middle half▲ 12.1pp-5.3%below the sector's middle half▼ 5.5pp9.0%within the sector's middle half▲ 14.3pp
Staff (FTE)11below the sector's middle half=1=1=1=1.5▲ 50.0%1.3within the sector's middle half▼ 13.3%
above
within
below
the middle half of NACE 70, Activities of head offices; management consultancy activities: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30.
The turnover shown is an estimate from the gross margin.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €859,421
Fixed assets
€447,785 ▼ 13.9%
Current assets
€411,636 ▲ 65.9%
Equity and liabilities €859,421
Equity
€815,663 ▲ 10.5%
Debt
€43,758 ▲ 46.6%
Debt's share of the balance-sheet total rises from 3.9% to 5.1%. Equity and debt are higher.
Key figures and ratios
EBITDA
€154,247▲
2024 · €52,051
Cash flow
€155,070▲
2024 · €52,407
Debt to equity
0.05▲
2024 · 0.04
ROE
9.5%▲
2024 · -5.5%
Interest coverage
over 100
2024 · over 100
Debt ≤ 1 year
€43,758▲
2024 · €29,851
Income taxes
€251▲
2024 · €237
Staff costs
€69,041▼
2024 · €87,359
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 31,368 companies that looked in July 2024 the way this one looks now, 0.5% went bankrupt within 24 months and 93.5% are still going.
- Micro
- 20 years or older
- solvency 30% or more
- a profit of 5% of the balance sheet or more
0.5%
went bankrupt
5.9%
stopped otherwise
93.5%
still going
A further 0.1% stopped, but we cannot tell whether within those 24 months.
For this company itself Checked computes a bankruptcy probability of < 0.1% over twelve months; the group does not contradict it.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,445 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74.5% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 31,368 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Annual accounts
| Line | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|---|
| Remuneration, social security and pensions62 | - | - | - | €46,241 | €48,305 | €53,908 | €87,359 | €69,041 | ▼ 21.0% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | - | €89,872 | €90,223 | €90,483 | €90,606 | €91,060 | €92,977 | €77,541 | ▼ 16.6% |
| Other operating charges640/8 | - | - | - | €3,909 | €4,490 | €5,195 | €5,580 | €6,871 | ▲ 23.1% |
| Gross operating margin9900 | €88,901 | €88,242 | €80,449 | €95,883 | €49,567 | €151,445 | €144,990 | €230,159 | ▲ 58.7% |
| Operating profit (loss)9901 | €85,117 | -€26,396 | -€63,246 | -€44,750 | -€93,834 | €1,282 | -€40,926 | €76,706 | - |
| Financial income75/76B | - | - | - | - | - | €277 | €790 | €1,518 | ▲ 92.2% |
| Recurring financial income75 | €60,000 | - | - | - | - | €277 | €790 | €1,518 | ▲ 92.2% |
| Financial charges65/66B | - | - | - | €99 | €108 | €143 | €197 | €444 | ▲ 125% |
| Recurring financial charges65 | €48 | €67 | €76 | €99 | €108 | €143 | €197 | €444 | ▲ 125% |
| Profit (loss) for the period before taxes9903 | €145,069 | -€26,463 | -€63,322 | -€44,849 | -€93,942 | €1,416 | -€40,333 | €77,780 | - |
| Income taxes67/77 | - | - | - | - | - | - | €237 | €251 | ▲ 5.9% |
| Profit (loss) for the period9904 | €145,069 | -€26,463 | -€63,322 | -€44,849 | -€93,942 | €1,416 | -€40,570 | €77,529 | - |
| Profit (loss) for the period to be appropriated9905 | €145,069 | -€26,463 | -€63,322 | -€44,849 | -€93,942 | €1,416 | -€40,570 | €77,529 | - |
| Line | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Total assets20/58 | €1.0m | €1.0m | €1.0m | €0.9m | €0.8m | €0.8m | €0.8m | €0.9m | ▲ 11.9% |
| Fixed assets21/28 | €1.0m | €0.9m | €0.9m | €0.8m | €0.7m | €0.6m | €0.5m | €0.4m | ▼ 13.9% |
| Tangible fixed assets22/27 | €1.0m | €0.9m | €0.9m | €0.8m | €0.7m | €0.6m | €0.5m | €0.4m | ▼ 13.9% |
| Land and buildings22 | - | - | - | €0.8m | €0.7m | €0.6m | €0.5m | €0.4m | ▼ 14.4% |
| Furniture and vehicles24 | - | - | - | - | - | €0.005m | €0.004m | €0.006m | ▲ 57.6% |
| Financial fixed assets28 | - | €50 | €50 | €50 | €50 | €50 | €50 | €50 | = |
| Current assets29/58 | €0.009m | €0.03m | €0.09m | €0.1m | €0.1m | €0.2m | €0.2m | €0.4m | ▲ 65.9% |
| Stocks and contracts in progress3 | - | - | €0.03m | - | - | - | - | - | - |
| Amounts receivable within one year40/41 | - | - | €0.005m | - | - | €0.04m | €0.001m | - | - |
| Trade receivables40 | - | - | - | - | - | €0.04m | - | - | - |
| Other amounts receivable41 | - | - | - | - | - | - | €0.001m | - | - |
| Cash at bank and in hand54/58 | €0.007m | €0.03m | €0.05m | €0.1m | €0.1m | €0.2m | €0.2m | €0.4m | ▲ 67.6% |
| Deferred charges and accrued income490/1 | - | - | - | €0.001m | €0.001m | €0.003m | €0.003m | €0.003m | ▼ 3.2% |
| Equity and liabilities | |||||||||
| Total equity and liabilities10/49 | €1.0m | €1.0m | €1.0m | €0.9m | €0.8m | €0.8m | €0.8m | €0.9m | ▲ 11.9% |
| Equity10/15 | €1.0m | €1.0m | €0.9m | €0.9m | €0.8m | €0.8m | €0.7m | €0.8m | ▲ 10.5% |
| Contributions10/11 | €1.5m | €1.5m | €1.5m | €1.5m | €1.5m | €1.5m | €1.5m | €1.5m | = |
| Capital10 | - | - | - | €1.5m | €1.5m | €1.5m | €1.5m | €1.5m | = |
| Issued capital100 | - | - | - | €1.5m | €1.5m | €1.5m | €1.5m | €1.5m | = |
| Reserves13 | €0.001m | €0.001m | €0.001m | €0.001m | €0.001m | €0.001m | €0.001m | €0.001m | = |
| Non-distributable reserves130/1 | - | - | - | €0.001m | €0.001m | €0.001m | €0.001m | €0.001m | = |
| Legal reserve130 | - | - | - | €0.001m | €0.001m | €0.001m | €0.001m | €0.001m | = |
| Profit (loss) carried forward14 | -€0.5m | -€0.5m | -€0.6m | -€0.6m | -€0.7m | -€0.7m | -€0.7m | -€0.7m | ▲ 10.4% |
| Amounts payable17/49 | €0.04m | €0.003m | €0.03m | €0.009m | €0.01m | €0.03m | €0.03m | €0.04m | ▲ 46.6% |
| Amounts payable within one year42/48 | €0.04m | €0.003m | €0.03m | €0.009m | €0.01m | €0.03m | €0.03m | €0.04m | ▲ 46.6% |
| Trade debts44 | €0.003m | €0.003m | €0.03m | - | €0.001m | €0.001m | €0.001m | €14 | ▼ 98.0% |
| Suppliers440/4 | - | - | - | - | €0.001m | €0.001m | €0.001m | €14 | ▼ 98.0% |
| Taxes, remuneration and social security45 | - | - | - | €0.009m | €0.009m | €0.03m | €0.03m | €0.04m | ▲ 50.1% |
| Taxes450/3 | - | - | - | €0.004m | €0.003m | €0.02m | €0.02m | €0.04m | ▲ 64.8% |
| Remuneration and social security454/9 | - | - | - | €0.006m | €0.006m | €0.007m | €0.006m | €0.005m | ▼ 11.8% |
| Line | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €145,069 | -€26,463 | -€63,322 | -€44,849 | -€93,942 | €1,416 | -€40,570 | €77,529 | - |
| + Depreciation and write-downs630 | - | €89,872 | €90,223 | €90,483 | €90,606 | €91,060 | €92,977 | €77,541 | ▼ 16.6% |
| Operating cash flow (approximation) | €145,069 | €63,409 | €26,901 | €45,634 | -€3,336 | €92,476 | €52,407 | €155,070 | ▲ 196% |
| Investment in fixed assets (approximation) | - | -€50 | -€5,909 | -€642 | -€909 | -€18,595 | €0 | -€5,420 | - |
| Change in cash | - | €24,763 | €20,996 | €51,077 | -€4,087 | €51,284 | €92,593 | €164,994 | ▲ 78.2% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Latest 10 of 42 filings with the National Bank
| Financial year | Type | Filed | Reference |
|---|---|---|---|
| 31-12-2025 | abbreviated format | 30-06-2026 | 2026-00242806 |
| 31-12-2024 | micro format | 14-07-2025 | 2025-00276115 |
| 31-12-2023 | micro format | 06-08-2024 | 2024-00333540 |
| 31-12-2022 | micro format | 23-08-2023 | 2023-00351205 |
| 31-12-2021 | micro format | 16-08-2022 | 2022-20292743 |
| 31-12-2020 | full format | 09-08-2021 | 2021-47200420 |
| 31-12-2019 | full format | 25-08-2020 | 2020-45100510 |
| 31-12-2018 | full format | 08-08-2019 | 2019-44900088 |
| 31-12-2017 | full format | 20-07-2018 | 2018-35900148 |
| 31-12-2016 | full format | 03-07-2017 | 2017-26400051 |
Similar companies · same sector, comparable size
TRI-VIZOR
BE 0807.875.386
Mechelen · equity €815,709
COMAPEX
BE 0423.738.065
Brussel · equity €815,837
ETABLISSEMENTS MERCKX
BE 0442.559.827
Enghien · equity €815,914
GEOS Laboratories - site Herstal
BE 0477.178.335
Herstal · equity €815,297
CODEFO
BE 0894.642.579
Deinze · equity €816,196
Of the 82,509 active companies whose main activity is business and other management consultancy (NACE 70200), figures are known for 54,646. 30,427 are within a factor 10 of this equity. These 5 are the closest to it. See the whole sector
Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.
Directors
Directors
2 directors, 1 in day-to-day management, last change in 2023
Board 2
FINPHARMA
CurrentDirector · since 11-01-2023 · Legal entity · permanent representative: BOULANGER Philippe
Hecq Pierre
CurrentDirector
Day-to-day management 1
Hecq Pierre
CurrentManaging director
Permanent representatives 1
BOULANGER Philippe
CurrentPermanent representative · since 11-01-2023 · for FINPHARMA
Derived from published Gazette deeds. The KBO keeps the official list of office holders; we do not read it, so the two can differ.
See the directors and other office holders in the KBO →
Not every act has been read: a resignation may still be missing
7 of this company's 9 Belgian Official Gazette deeds have not been read yet. Appointments and resignations recorded in them are not yet in the list of directors: someone who resigned there may still be listed as sitting. The acts are in the Timeline.
Mandate history
4 people since 2023, 2 in office
- Board
- Day-to-day management
- began earlier
| Name | Functions and periods |
|---|---|
| FINPHARMA |
|
| Hecq Pierre |
|
| ASSCOT |
|
| UNIVERSAL PHARMA |
|
Owners and capital
Capital and shareholders
Capital over the years
- 11-01-2023 Capital stated in the deed · 59,862 shares
Group and network
Holdings and subsidiaries
1 holdingHoldings 1
- FINANCIERE DU LOUVYsubsidiarySourceact 19-01-2026100%
Sources: the companies' annual accounts, the acts in the Belgian Official Gazette and the LEI register. Annual accounts state the shareholders that notified the company under article 7:225 of the Code of Companies and Associations and the parent companies that consolidate it. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not include these statements in its annual accounts, or does not have to, is not listed.
Connections & network
7 connected companiesThis company
Company
Director
Shareholding
+N: links not shown yet
Click a node to look further, drag to arrange, zoom with the mouse wheel.
Linked via shared directors
MS Marketing Belgium
via Hecq Pierre · Director (not named in the articles)
→
BOURGEOIS OPTICIENS
via Hecq Pierre · Director
former→
CLIC & NET SERVICES
via Hecq Pierre · Director
former→
Show 3 more companies with a shared director
EKOSERVICES JURBISE
via Hecq Pierre · Director
former→
EKOSERVICES REGION DU CENTRE
via Hecq Pierre · Director
former→
former→
Board mandates elsewhere
4 board mandatesBoard mandates of this companythis company sits on their board4
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
30-06
NBB filing
Annual accounts filed
financial year 2025 · abbreviated format
2025
31-12
Financial
Back to profitnet €77,529
Net result €77,529 after one loss-making year.
14-07
NBB filing
Annual accounts filed
financial year 2024 · micro format
2024
25-11
Gazette deed
Reappointments: FINPHARMA (director) and HECQ Pierre-Pascal (director)Director discharge6 facts ▸
Gazette deed
Reappointments: FINPHARMA (director) and HECQ Pierre-Pascal (director)
Director discharge6 facts ▸
- General meeting, 03-06-2024
- General meeting, 25-11-2022
- Director reappointment, FINPHARMA (director)
- Director reappointment, HECQ Pierre-Pascal (director)
- Director reappointment, HECQ Pierre-Pascal (managing director)
- Director discharge, HECQ Pierre-Pascal
06-08
NBB filing
Annual accounts filed
financial year 2023 · micro format · 6 days late
2023
31-12
Financial
Back to profitnet €1,416
Net result €1,416 after 4 loss-making years.
23-08
NBB filing
Annual accounts filed
financial year 2022 · micro format · 23 days late
11-01
Gazette deed
Reappointment: HECQ Pierre Pascal (director)Appointment: FINPHARMA (director) · Permanent representatives: BOULANGER Philippe and HECQ Pierre Pascal · Resignations: UNIVERSAL PHARMA (director) and ASSCOT (director)14 facts ▸
Gazette deed
Reappointment: HECQ Pierre Pascal (director)
Appointment: FINPHARMA (director) · Permanent representatives: BOULANGER Philippe and HECQ Pierre Pascal · Resignations: UNIVERSAL PHARMA (director) and ASSCOT (director)14 facts ▸
- General meeting, 25-11-2022
- Amendment of the articles
- Capital
- Power of attorney, Christophe CAUCHIES
- Director reappointment, HECQ Pierre Pascal (director)
- Director reappointment, HECQ Pierre Pascal (managing director)
- Director appointment, FINPHARMA (director (not named in the articles))
- Permanent representative, BOULANGER Philippe (director and permanent representative)
- Director resignation, UNIVERSAL PHARMA (director)
- Director resignation, ASSCOT (director)
- Director discharge, UNIVERSAL PHARMA
- Director discharge, ASSCOT
- +2 further facts in this act
2022
31-12
Financial
Weakest financial yearnet -€93,942
Net result drops to -€93,942, the lowest in the series; recovery starts the following year.
16-08
NBB filing
Annual accounts filed
financial year 2021 · micro format · 16 days late
2021
31-12
Financial
Liquidity more than quadruplescurrent ratio 11.34
Current ratio from 2.47 to 11.34; short-term debt falls from €34,831 to €9,304.
09-08
NBB filing
Annual accounts filed
financial year 2020 · full format · 9 days late
Show earlier events
2020
25-08
NBB filing
Annual accounts filed
financial year 2019 · full format · 25 days late
2019
31-12
Financial
Liquidity more than 51 timescurrent ratio 10.52
Current ratio from 0.20 to 10.52; short-term debt falls from €41,677 to €3,171.
08-08
NBB filing
Annual accounts filed
financial year 2018 · full format · 8 days late
2018
20-07
NBB filing
Annual accounts filed
financial year 2017 · full format
2017
03-07
NBB filing
Annual accounts filed
financial year 2016 · full format
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 42 annual accounts filed, the latest 10 are here; all 42 are under Financials.
2 of 9 deeds read
About the unread acts
Of the 9 Belgian Official Gazette deeds we know for this company, 2 have been read. The other 7 have not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Register details
Identification
Legal formPublic limited company
Founded31-12-1983
Financial year end31-12
Activities, NACEBEL 2025
70200Business and other management consultancy
E-invoicing
Reachable via Peppol
Peppol ID
0208:0425530684
Also
9925:BE0425530684
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 31 October 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.
Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.
Sites & property
Location & real-estate footprint
Registered office, Mons · 1 establishment unit since 1984
Ground area
1.1 ha
Building footprint
5,263 m²
Building volume
27,147 m³
2 parcels, Wallonia · tallest building 13.7 m. Linked by address, not a title deed.
1 establishment unit
Rue Montavaux 155, 7080 Frameries
since 1984unit no. 2.024.258.653
2 parcels
Wallonia
2
(100%)
| Cadastral parcel | Region | Area | Buildings | Height / floors |
|---|---|---|---|---|
| 53028A0282/00E003 | Wallonia | 7,354 m² | 1 · 5,065 m² | 6.3 m · 2 |
| 53042B0175/00S000 | Wallonia | 3,379 m² | 1 · 197 m² | 13.7 m · 4 |
How the parcels are linked
Good to know
Both parcels match the address exactly.
Articles of association
What the company does
- PurposeThe activities the company may carry out under its articles.
- “Toutes prestations de services et tous actes quelconques dans le cadre du management des entreprises dans son acceptation la plus large…” (deed in French)
8 activities (deed in French)
- Toutes prestations de services et tous actes quelconques dans le cadre du management des entreprises dans son acceptation la plus large
- Toutes opérations immobilières,l'achat,la vente,l'échange,la location,le courtage,la négociation,la publicité,le lotissement,la construction,la transformation d'immeubies et la promotion immobilière et générale et tout ce qui s'y rapporte directement ou indirectement
- Tout ce qui est utile ou nécessaire à l'accomplissement de son objet social
- Exercer les fonctions d'administrateur,de liquidateur,de gérant dans toutes autres sociétés civiles ou commerciales
- Toutes prestations liées au développement de la clientèle,de gestion de sociétés,de constitution d'entreprises,de restructuration,de liquidation de branche d'activités et de sociétés
- Se porter caution au profit de ses propres administrateurs et actionnaires
- Toutes opérations commerciales,industrielles ou financières,mobilières ou immobilières,se rapportant directement ou indirectement à son objet social ou qui serait de nature à en faciliter directement ou indirectement,entièrement ou partiellement ta réalisation
- S'intéresser par voie d'apport,de fusion,de souscription,de prise de participation,ou de toute autre manière dans toute affaire,entreprise,association ou société ayant un objet ou une activité identique,analogue,connexe ou complémentaire au sien ou qui sont de nature à favoriser le développement de son entreprise et à lui procurer des matières premières ou à faciliter l'écoulement de ses produits
- DurationHow long the company exists; usually unlimited, so until it is dissolved.
- Unlimited
- Name clauseThe name the company operates under according to its articles.
- GESTIPHARMA
- Registered office clauseThe region of the registered office; it decides among other things the language of official documents.
- “Région wallonne, organe d'administration” (deed in French)
Who represents it, and how
- Board ruleHow the board is made up, meets and takes decisions.
- “13, six ans” (deed in French)
- Power of attorneyA special mandate allowing someone to perform one or more acts on the company's behalf.
- One provision in the deed
Capital, shares and profit
- Kind of sharesWhich classes of shares exist and what rights each class carries.
- “Nominatives, tout actionnaire” (deed in French)
- Transfer restrictionWhether shareholders may sell their shares freely or need approval first.
- “Moitié cédant moitié cessionnaire(s), cessions et transmissions à tiers non-actionnaires soumises à litera B et litera C” (deed in French)
Meetings and financial year
- Annual meetingWhen the shareholders meet each year, among other things to approve the annual accounts.
- First Monday of June at 15:00
Oversight and winding up
- Liquidation ruleHow assets are shared after dissolution: creditors first, then shareholders.
- “Dissolution pour quelque raison que ce soit et à tout moment, organe d administration en fonction en collège de liquidateurs” (deed in French)1 more provision on this in the deed